New NIH CFAR Ending the HIV Epidemic Supplement Recipient: Sarah Henn, MD, MPH

Dr. Sarah Henn
October 28, 2019

Sarah Henn, MD, MPH (Whitman-Walker Health) has been awarded an NIH CFAR Administrative supplement titled, “A City-Wide Approach to HIV Pre-Exposure Prophylaxis (PrEP) Scale Up in Multiple High-Risk Communities in Washington D.C.” This project will address the “Prevent” pillar of the nationwide Ending the HIV (EHE) initiative.


Pre-Exposure Prophylaxis (PrEP) allows individuals at-risk for HIV infection to take medication to prevent transmission. Despite strong evidence suggesting PrEP reduces the risk of HIV infection 83.5%-100% in high risk populations, multiple barriers have hindered large scale uptake including lack of awareness, access challenges, fear of stigma, mistrust of the health system, and provider bias. Despite efforts to address these obstacles in DC, key populations that make up the majority of new HIV cases in DC, including communities of color and women, are vastly underrepresented among those currently seeking PrEP in the DC. This project seeks to use an implementation science framework in partnership with the DC Department of Health (DC Health) to expand uptake of PrEP for those most at risk of HIV acquisition, including a particular focus on African American men who have sex with men (MSM) and women, Latinx MSM, transgender women, adolescents and youth, and persons who use drugs.

Click here for more information on NIH CFAR Ending the HIV Epidemic Supplements.